|
PABPC4L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.783200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.854450E-02 |
| Normal-vs-Stage2 |
9.662200E-01 |
| Normal-vs-Stage3 |
8.893000E-01 |
| Normal-vs-Stage4 |
6.550200E-01 |
| Stage1-vs-Stage2 |
3.122400E-01 |
| Stage1-vs-Stage3 |
9.908100E-02 |
| Stage1-vs-Stage4 |
6.480600E-01 |
| Stage2-vs-Stage3 |
8.968800E-01 |
| Stage2-vs-Stage4 |
7.459600E-01 |
| Stage3-vs-Stage4 |
6.334800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.089700E-02 |
| Normal-vs-AfricanAmerican |
8.067600E-02 |
| Normal-vs-Asian |
8.120800E-01 |
| Caucasian-vs-AfricanAmerican |
7.372800E-01 |
| Caucasian-vs-Asian |
5.170000E-01 |
| AfricanAmerican-vs-Asian |
4.470400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.979900E-03 |
| Normal-vs-Female |
5.442600E-01 |
| Male-vs-Female |
1.021030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.212000E-01 |
| Normal-vs-Extreme_Weight |
3.625800E-02 |
| Normal-vs-Obese |
9.324300E-02 |
| Normal-vs-Extreme_Obese |
1.851630E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.747600E-01 |
| Normal_Weight-vs-Obese |
9.261800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.420400E-02 |
| Extreme_Weight-vs-Obese |
5.119400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.161500E-02 |
| Obese-vs-Extreme_Obese |
1.389010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.593800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.320400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.533830E-01 |
| Normal-vs-Age(81-100Yrs) |
7.047400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.242000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.268400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.474800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.687900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.630790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.231000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.13579999999558E-05 |
| Normal-VS-Type2 PRCC |
4.244500E-03 |
| Normal-VS-KIRP CIMP |
5.196700E-03 |
| Normal-VS-Unclassified PRCC |
7.247600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.48880044245925E-10 |
| Type1 PRCC-VS-KIRP CIMP |
7.5244000030672E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.390800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.236200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.459000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.001910E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.682600E-01 |
| Normal-vs-N1 |
8.237000E-01 |
| Normal-vs-N2 |
9.166500E-02 |
| N0-vs-N1 |
8.162000E-01 |
| N0-vs-N2 |
3.360200E-01 |
| N1-vs-N2 |
4.637600E-01 |
|
|
